ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2025
Antenatal dexamethasone for late preterm delivery: Rate of complete course and neonatal outcomes.
Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antenatal dexamethasone for late preterm delivery: Rate of complete course and neonatal outcomes.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveThis retrospective cohort study aimed to assess the rate of complete dexamethasone administration among late preterm deliveries and its impact on neonatal outcomes.
methodsWe reviewed medical records of 1500 late preterm deliveries (gestational age 34-36 + 6 weeks) between January 2018 and December 2020, analyzing baseline characteristics, dexamethasone administration, and pregnancy outcomes. Neonatal outcomes were evaluated separately for singletons and twins, comparing three groups: complete course, incomplete course, and no dexamethasone.
resultsThe overall rate of complete dexamethasone administration was 31.7%, varying between singletons (29.2%) and twins (48.4%). Singleton pregnancies receiving the complete course had significantly lower odds of Apgar scores <7 at 5 min compared with the incomplete course and no-dexamethasone groups (adjusted risk ratio [aRR] 0.22, 95% confidence interval [CI] 0.05-0.94 and 0.11, 95% CI 0.02-0.64, respectively). Complete course recipients also had reduced odds of apnea compared with the incomplete group (aRR 0.32, 95% CI 0.13-0.78). In twin pregnancies, neonatal sepsis incidence was lower in the complete course group than in the incomplete and no-dexamethasone groups (aRR 0.02, 95% CI 0.001-0.65 and 0.005, 95% CI 0.001-0.3, respectively). However, no significant differences were found in neonatal death or severe morbidity in singleton pregnancies. Neonatal sepsis was reduced in twins who received a complete course of dexamethasone.
conclusionApproximately one-third of late preterm pregnancies received a complete dexamethasone course. Although neonatal death and severe morbidity were similar across groups, the complete course group showed improved respiratory outcomes in singletons and lower neonatal sepsis incidence in twins. However, these findings should be interpreted with caution due to the limited sample size and wide confidence intervals, which indicate potential uncertainty in the estimates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.